Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals

Journal of General Virology

Volumn 77, Issue 7, 1996, Pages 1585-1593

  Luxton, Jenny C ^a   Rowe, Andrea J ^a   Cridland, Jeremy C ^a   Coletart, Timothy ^b   Wilson, Philip ^b   Shepherd, Philip S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CANCER GRADING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HELPER CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; WART VIRUS;

EID: 0029885447     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-7-1585     Document Type: Article

References (30)

1. Altmann, A., Jochmus-Kudielka, I., Frank, R., Gausepohl, H., Moebius, U., Gissman, L. & Meuer, S. C. (1992). Definition of immunogenic determinants of the human papillomavirus type 16 nucleoprotein E7. European Journal of Cancer 28, 326-333.
2. Chambers, M. A., Stacey, S. N., Arrand, J. R. & Stanley, M. A. (1994a). Delayed-type hypersensitivity response to human papillomavirus type 16 E6 protein in a mouse model. Journal of General Virology 75, 165-169.
3. Chambers, M. A., Wei, Z., Coleman, N., Nash, A. A. & Stanley, M. A. (1994b). 'Natural' presentation of human papillomavirus type 16 E7 protein to immunocompetent mice results in antigen specific sensitisation or sustained unresponsiveness. European Journal of Immunology 24, 738-745.
4. Coleman, N., Birley, H. D., Renton, A. M., Hanna, N. F., Ryait, B. K., Byrne, M., Taylor-Robinson, D. & Stanley M. A. (1994). Immunological events in regressing genital warts. American Journal of Clinical Pathology 102, 768-774.
5. Comerford, S. A., McCance, D. J., Dougan, G. & Tite, J. P. (1991). Identification of T- and B-cell epitopes of the E7 protein of human papillomavirus type 16. Journal of Virology 65, 4681-4690.
6. Ellis, J. R. M., Keating, P. J., Baird, J., Hounsell, E. F., Renouf, D. V., Rowe, M., Hopkins, D., Duggan-Keen, M. F., Bartholomew, J. S., Young, L. S. & Stern, P. L. (1995). The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature Medicine 1, 464-470.
7. Feltkamp, M. C., Smits, H. L., Vierboom, M. P., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. & Kast, W. M. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. European Journal of Immunology 23, 2242-2249.
8. Hildesheim, A., Tsukui, T., Schiffman, M. H., Swanson, C. A., Lawler, P., Rush, B. B., Lorincz, A. T., Corrigan, A., Carbone, D., Scott, D. R., Lucci, J., Houghten, R. A., Kramer, T. & Berzofsky, J. A. (1995). T-cell response to HPV and cervical neoplasia: results from a cross-sectional study of IL-2 production and sIL-2R levels among 196 women with and without SIL. 14th International Papillomavirus Conference, Quebec, Canada, p. 175.
9. Houghten, R. (1985). General method for the rapid solid phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acid. Proceedings of the National Academy of Sciences, USA 82, 5131-5135.
10. Johnson, J. C., Burnett, A. F., Willet, G. D., Young, M. A. & Doniger, J. (1992). High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstetrics and Gynecology 79, 321-327.
11. Kadish, A. S., Romney, S. L., Ledwidge, R., Tindle, R., Fernando, G. J. P., Zee, S. Y., Van Ranst, M. A. & Burk, R. D. (1994). Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependant on the HPV type infecting the cervix whereas serological reactivity is not type specific. Journal of General Virology 75, 2277-2284.
12. Kast, W. M., Brandt, R. M., Drijfhout, J. W. & Melief, C. J. (1993). Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing defective human cell line T2. Journal of Immunotherapy 14, 115-120.
13. Kast, W. M., Brandt, R. M., Sidney, J., Drijfhout, J. W., Kubo, R. T., Grey, H. M., Melief, C. J. & Sette, A. (1994). Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. Journal of Immunology 152, 3904-3912.
14. McLean, C. S., Sterling, J. S., Mowat, J., Nash, A. A. & Stanley, M. A. (1993). Delayed-type hypersensitivity response to the human papillomavirus type 16 E7 protein in a mouse model. Journal of General Virology 74, 239-245.
15. Manos, M. M., Wright, D. K., Lewis, A. J., Broker, T. R. & Wolinsky, S. M. (1989). The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In Molecular Diagnostics of Human Cancer, Cancer Cells 7, pp. 209-214. Edited by M. Furth & M. Greaves. New York: Cold Spring Harbor Laboratory.
16. Marston, F. A. O. (1986). The purification of eukaryotic polypeptides synthesised in Escherichia coli. Biochemical Journal 240, 1-12.
17. Melbye, M., Palefsky, J., Gonzales, J., Ryder, L. P., Nielsen, H., Bergmann, O., Pindborg, J. & Biggar, R. J. (1990). Immune status as a determinant of human papillomavirus detection and its association with anal epithelial abnormalities. International Journal of Cancer 46, 203-206.
18. Porreco, R., Penn, I., Droegemueller, W., Greer, B. & Makowski, E. (1975). Gynecological malignancies in immunosuppressed organ homograft recipients. Obstetrics & Gynecology 45, 359-364.
19. Resnick, R. M., Cornelissen, M. T., Wright, D. K., Eichinger, G. H., Fox, H. S., ter Schegget, J. & Manos, M. M. (1990). Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. Journal of the National Cancer Institute 62, 1477-1484.
20. Sadovnikova, E., Zhu, X., Collins, S. M., Zhou, J., Vousden, K., Crawford, L., Beverley, P. & Stauss, H. J. (1994). Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papillomavirus E7 protein. International Immunology 6, 289-296.
21. Shepherd, P. S., Tran, T. T. T., Rowe, A. J., Cridland, J. C., Comerford, S. A., Chapman, M. G. & Rayfield, L. S. (1992). T-cell responses to the human papillomavirus type 16 E7 protein in mice of different haplotypes. Journal of General Virology 73, 1269-1274.
22. Shepherd, P. S., Rowe, A., Cridland, J., Chapman, M., Luxton, J. & Rayfield, L. (1994). An immunodominant region in HPV16 L1 identified by T cell responses in patients with cervical dysplasias. In Immunology of Human Papillomaviruses, pp. 169-174. Edited by M. A. Stanley. New York: Plenum Press.
23. Shepherd, P. S., Rowe, A. J., Cridland, J. C., Coletart, T., Wilson, P. & Luxton, J. C. (1996). Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia. Journal of General Virology 77, 593-602.
24. Smith, D. B. & Johnson, K. S. (1988). Single step purification of polypeptides expressed in E. coli as fusions with glutathione-S-transferase. Gene 67, 31-40.
25. Snijders, P. J. F., van den Brule, A. J. C., Schrijnemakers, H. F. J., Snow, G., Meijer, C. J. L. M. & Walboomers, A. J. M. M. (1990). The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. Journal of General Virology 71, 173-181.
26. Strang, G., Hickling, J. K., McIndoe, G. A. J., Howland, K., Wilkinson, D., Ikeda, H. & Rothbard, J. B. (1990). Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. Journal of General Virology 71, 423-431.
27. Tindle, R. W., Fernando, G. J. P., Sterling, J. C. & Frazer, I. H. (1991). A public T-helper cell epitope of the E7 transforming protein of human papillomavirus type 16 provides cognate help for several E7 B-cell epitopes from cervical cancer associated human papillomavirus genotypes. Proceedings of the National Academy of Sciences, USA 88, 5887-5891.
28. Tindle, R. W., Herd, K., Londono, P., Fernando, G. J., Chatfield, S. N., Malcolm, K. & Dougan, G. (1994). Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunized mice. Virology 200, 547-557.
29. van den Brule, A. J., Snijders, P. J., Raaphorst, P. M., Schrijnemakers, H. F., Delius, H., Gissmann, L., Meijer, C. J. & Walboomers, J. M. (1992). General primer polymerase chain reaction in combination with sequence analysis for identification of potentially novel human papillomavirus genotypes in cervical lesions. Journal of Clinical Microbiology 30, 1716.
30. Wright, D. & Manos, M. (1990). Sample preparation from paraffin-embedded tissues. In PCR Protocols: A Guide to Methods and Applications, pp. 153-158. Edited by M. A. Innis, D. H. Gelfand, J. J. Sninsky & T. J. White. San Diego: Academic Press.